查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2006340

超音波针导向器市场：全球市场按产品类型、操作模式、影像类型、最终用户和应用进行预测——2026-2032年

Ultrasound Needle Guides Market by Product Type, Operation Mode, Imaging Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，超音波针导向器市场价值将达到 2.8356 亿美元，到 2026 年将成长至 3.0064 亿美元，到 2032 年将达到 4.452 亿美元，复合年增长率为 6.65%。

主要市场统计数据
基准年 2025 2.8356亿美元
预计年份：2026年 3.064亿美元
预测年份 2032 4.452亿美元
复合年增长率 (%) 6.65%

超音波针导向器的权威概述：提出了临床效用、操作整合以及影响采用和创新的相关人员之间的动态框架。

超音波导引针已成为多种经皮手术中不可或缺的工具，在提升影像清晰度和手术精准度方面发挥着至关重要的作用。临床医生依靠这些导引针来提高视野清晰度、缩短手术时间并最大限度地减少併发症，例如在进行局部麻醉、切片检查和血管通路等操作时。随着超音波系统的不断发展，用于辅助针头引导的配件也随之发展，更加重视人体工学、相容性和无菌性。

临床需求、影像技术的进步和营运重点如何交织，重新定义针导向工具的产品差异化、手术流程和采购标准？

超音波引导针的市场格局正因技术、临床和营运方面的变革而重塑，这些变革共同重新定义了医疗服务提供者的价值提案。影像品质的提升以及先进的二维、3D和四维成像技术的广泛应用，提高了人们对引导针精度的期望。这使得门诊手术中心、影像中心、诊所、医院和医疗机构能够进行更复杂的介入治疗。随着成像技术的日益精进，引导针解决方案必须具备系统一致性、易用性和相容性。

关税调整对超音波针导引器供应商和买家的采购韧性、製造本地化和供应连续性的连锁反应。

贸易政策的变化和关税调整给超音波配件生态系统中的供应链规划人员、采购团队和製造商带来了新的挑战。由于关税会影响零件和成品的采购成本，製造商必须重新评估筹资策略、定价模式和库存政策，以履行合约义务并维持对临床医生的供应。这一趋势会影响一次性产品线和可重复使用产品线，并可能对前置作业时间和供应商选择产生连锁反应。

将产品类型、操作模式、成像需求、最终用户特征和特定应用要求与商业性和临床策略相结合的策略性细分洞察。

精准的市场细分对于使产品线和商业策略与临床及营运实际情况相符至关重要。根据产品类型，市场可分为「一次性」和「可重复使用」两大类进行分析。这为讨论感染控制、单例成本、废弃物管理和消毒物流等问题奠定了基础。处理能力强或感染控制通讯协定严格的机构往往倾向于选择一次性产品，而优先考虑永续性和单位产品生命週期的机构则倾向于选择具有完善清洁通讯协定的可重复使用产品。

美洲、欧洲、中东和非洲以及亚太地区的医疗保健系统、采购实务和供应链现实对采用趋势和商业性方法的影响。

区域趋势对超音波引导针的需求模式、监管预期和分销策略起着决定性作用。在美洲，门诊中心和医院的大量手术往往促使企业投资一次性解决方案，以支持高处理能力和感染控制；同时，紧密的私人诊所网络也造就了以快速交货和本地支持为核心的竞争格局。从急诊护理向门诊护理的转变持续影响供应商在销售和培训基础设施方面的投资方向。

临床检验、平台相容性和整合服务模式驱动的竞争动态正在塑造供应商定位和客户偏好。

超音波引导针的竞争格局正从单纯的商品价格战转向基于临床检验、系统相容性和服务差异化的竞争。主要企业正日益将硬体与临床医生培训计画、模拟平台和实施支援相结合，以降低应用门槛并展现该技术的价值。与影像系统製造商和医疗机构建立策略合作伙伴关係，能够增强整合并简化工作流程。

为製造商和供应商提供切实可行的倡议，以加快产品采用速度，降低供应风险，并透过有针对性的投资来证明其临床和营运价值。

产业领导企业可以透过协调产品开发、与临床医生合作以及增强供应链韧性，加速产品普及并确立强大的市场地位。优先考虑跨平台相容性，以减少临床团队内部的摩擦，并拓展不同影像模式的应用场景。透过投资于能够提高针头可见性和稳定性且不增加手术复杂性的材料和设计特性，增强临床医生的信心并减轻训练负担。

采用严谨的混合方法，结合对临床医生的访谈、使用实际设备的产品评估以及监管和供应链分析，确保获得可操作且检验的见解。

本研究整合了从临床医生访谈、供应链相关人员咨询和产品检验审查中获得的第一手资料，并结合对法规结构和公开临床文献的结构化分析。临床医生的回馈来自广泛的使用者群体，包括医院、诊所、影像中心、门诊手术中心和医疗办公室，以了解治疗偏好和工作流程限制。供应链观点则透过与製造和分销合作伙伴的营运经理对话来整合，以揭示他们对筹资策略和前置作业时间的敏感度。

一份简洁、全面的分析报告，重点阐述了临床需求、营运实际情况和区域差异如何相互交织，从而塑造长期应用和竞争优势。

整体而言，超音波引导针的发展趋势是注重实用性创新和差异化价值创造。临床需求日益受到精准可靠引导的限制，这种引导方式需要与不断发展的影像技术和多样化的治疗环境无缝衔接。因此，人们更加重视相容性、稳定的供应和可证实的临床获益，而非单一设备的功能特性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：超音波针导引器市场：依产品类型划分

  • 一次性的
  • 可重复使用的

第九章：超音波针导引器市场：依操作模式划分

  • 自动的
  • 手动的

第十章：超音波针导向器市场：依影像类型划分

  • 3D和4D
  • QR 图

第十一章：超音波针导向器市场：依最终用户划分

  • 门诊手术中心
    • 医院管理
    • 独立设施
  • 诊断影像中心和医生
    • 诊断影像中心
    • 医生诊所
  • 医院和诊所
    • 私人诊所
    • 公立医院

第十二章：超音波针导引器市场：依应用领域划分

  • 麻醉
    • 全身
    • 局部A
  • 切片检查
    • 芯针
    • 细针
  • 血管通路
    • 中央静脉导管置入术
    • 外围设备接入

第十三章：超音波针导引器市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：超音波针导引器市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：超音波针导引器市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国：超音波针导引器市场

第十七章 中国：超音波针导引器市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Argon Medical Devices Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • CIVCO Medical Solutions
  • Clarius Mobile Health
  • Cook Medical Inc.
  • EchoNous Inc.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Systems
  • Interson Corporation
  • Medtronic plc
  • Mindray Medical International Limited
  • Philips Healthcare
  • Rocket Medical plc
  • Samsung Medison Co. Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Stryker Corporation
  • Telemed Ultrasound
Product Code: MRR-6723692286C8

The Ultrasound Needle Guides Market was valued at USD 283.56 million in 2025 and is projected to grow to USD 300.64 million in 2026, with a CAGR of 6.65%, reaching USD 445.20 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 283.56 million
Estimated Year [2026] USD 300.64 million
Forecast Year [2032] USD 445.20 million
CAGR (%) 6.65%

An authoritative overview of ultrasound needle guides that frames clinical utility, operational integration, and cross-stakeholder dynamics influencing adoption and innovation

Ultrasound needle guides have become integral to a wide range of percutaneous procedures, creating a nexus between imaging clarity and procedural precision. Clinicians rely on these guides to enhance visualization, reduce procedural time, and minimize complications when performing interventions such as regional anesthesia, biopsies, and vascular access. As ultrasound systems have evolved, so too have the accessory tools that support needle guidance, with emphasis on ergonomics, compatibility, and sterility.

From an operational perspective, the adoption of needle guides reflects a broader shift toward image-guided, minimally invasive care. Device designers and clinical teams collaborate to refine interface compatibility with two dimensional, three dimensional, and four dimensional imaging modalities, while hospital procurement and ambulatory centres increasingly prioritize disposability patterns and reuse protocols that balance cost with infection control. Clinical training and procedural standardization play a decisive role in driving consistent outcomes, making education and vendor support key determinants of successful deployments.

Beyond the immediate clinical utility, the ecosystem around needle guides encompasses manufacturers, imaging system partners, clinical educators, and regulatory stakeholders. Understanding the interplay among these actors clarifies where innovation is likely to emerge, which clinical use cases will expand, and how operational priorities such as throughput, patient comfort, and staff safety will shape procurement decisions in the near term.

How converging clinical needs, imaging advances, and operational priorities are redefining product differentiation, procedural workflows, and procurement criteria for needle guidance tools

The landscape for ultrasound needle guides is being reshaped by a confluence of technological, clinical, and operational shifts that together reframe value propositions for healthcare providers. Image quality improvements and the broader availability of advanced two dimensional, three dimensional and four dimensional imaging have raised expectations for guidance accuracy, enabling more complex interventions in ambulatory surgical centres, diagnostic imaging centres and physicians offices, and hospitals and clinics. As imaging becomes richer, needle guidance solutions must deliver congruent alignment, ease of use, and compatibility across systems.

Operationally, the move toward ambulatory care and same-day procedures has emphasized compact, disposable options that reduce sterilization overhead and turnaround time. At the same time, concerns about sustainability and long-term cost encourage ongoing development of reusable designs with robust cleaning and validation protocols. Advances in ergonomics, materials science, and modular adapter systems have made it easier for clinicians to integrate needle guides into existing workflows, while training platforms and simulation tools are closing the gap between technological capability and clinician proficiency.

Regulatory and reimbursement pathways are also evolving. Increased attention to infection prevention, procedural safety metrics, and quality reporting is prompting facilities to reassess device selection criteria beyond unit cost. Consequently, vendors that demonstrate strong clinical evidence, seamless compatibility with imaging platforms, and comprehensive post-sale support are gaining traction. These transformative shifts create new opportunities for differentiation based on clinical outcomes, usability, and lifecycle value rather than discrete device pricing alone.

The downstream effects of tariff adjustments on procurement resilience, manufacturing localization, and supply continuity for ultrasound needle guide suppliers and buyers

Trade policy shifts and tariff adjustments introduce new layers of complexity for supply chain planners, procurement teams, and manufacturers active in the ultrasound accessories ecosystem. When tariffs alter landed costs for components or finished products, manufacturers must reassess sourcing strategies, pricing models, and inventory policies to preserve contractual commitments and maintain availability to clinicians. This dynamic affects both disposable and reusable product lines and can have cascading effects on lead times and vendor selection.

Manufacturers facing increased import costs may accelerate efforts to localize critical production steps or to reconfigure bill of materials to reduce tariff exposure. Such changes frequently require validation testing and regulatory updates, which in turn influence time-to-market and commercial agility. Facilities that purchase needle guides must be attentive to potential short-term price variability and longer-term shifts in supplier footprints that could affect service and compatibility guarantees.

Procurement teams benefit from proactive vendor engagement that clarifies contingency planning, alternative sourcing options, and the potential for contractual protections against abrupt cost changes. Collaborative forecasting and transparent communication about inventory buffers help clinical teams avoid disruption to procedural schedules. In sum, tariff developments act as a trigger for supply chain resilience measures, greater emphasis on supplier diversification, and a reassessment of total cost of ownership across product portfolios.

Strategic segmentation insights that map product types, operation modes, imaging demands, end-user nuances, and application-specific requirements to commercial and clinical strategies

A nuanced understanding of segmentation is essential to align product offerings and commercial strategies with clinical and operational realities. Based on Product Type, market is studied across Disposable and Reusable, which frames conversations around infection control, per-case cost, waste management, and the logistics of sterilization. Facilities with high throughput or stringent infection protocols may prioritize disposables, while organizations focused on sustainability and per-unit lifecycle may favor reusable options with robust cleaning protocols.

Based on Operation Mode, market is studied across Automatic and Manual, which highlights user-interface and workflow differences. Automatic systems can reduce cognitive load and standardize needle alignment for certain procedures, whereas manual guides emphasize clinician control and simplicity, often preferred in variable anatomical contexts. Based on Imaging Type, market is studied across Three Dimensional Four Dimensional and Two Dimensional, with each imaging modality placing distinct demands on guide design, attachment mechanisms, and clinician training. Three dimensional and four dimensional imaging enable complex spatial navigation but require accessories that can articulate in multiple planes and maintain calibration.

Based on End User, market is studied across Ambulatory Surgical Centres, Diagnostic Imaging Centres And Physicians, and Hospitals And Clinics. The Ambulatory Surgical Centres is further studied across Hospital Owned and Independent Centres, reflecting differences in procurement policies and capital allocation. The Diagnostic Imaging Centres And Physicians is further studied across Imaging Centres and Physicians Offices, each with unique throughput and procedural mixes. The Hospitals And Clinics is further studied across Private Clinics and Public Hospitals, which diverge in regulatory frameworks and budget cycles. Based on Application, market is studied across Anesthesia, Biopsy, and Vascular Access. The Anesthesia is further studied across General and Regional, with distinct needle trajectories and sterility needs. The Biopsy is further studied across Core Needle and Fine Needle, affecting guide aperture and stability. The Vascular Access is further studied across Central Line Placement and Peripheral Access, where varying depths and vessel sizes necessitate different alignment tolerances.

Taken together, segmentation clarifies where product development should focus, how training curricula should be tailored, and which commercial approaches resonate with specific buyer personas. This layered view supports targeted clinical validation strategies and helps vendors craft differentiated value propositions for each end-user cohort.

How regional healthcare structures, procurement behaviors, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercial approaches

Regional dynamics play a decisive role in shaping demand patterns, regulatory expectations, and distribution strategies for ultrasound needle guides. In the Americas, procedural volumes in ambulatory centres and hospitals often drive investment in disposable solutions to support high throughput and infection control priorities, while a dense network of private clinics fosters a competitive supplier landscape focused on rapid fulfillment and localized support. Transitioning from acute care to outpatient settings continues to influence where suppliers invest in sales and training infrastructure.

In Europe, Middle East & Africa, procurement patterns are heterogeneous: Western European markets typically emphasize clinical evidence and long-term service relationships, while parts of the Middle East and Africa may prioritize supply reliability and rapid access to consumables. Variation in public versus private healthcare provision, regulatory harmonization, and reimbursement pathways requires nuanced market entry strategies and adaptive pricing models. Regional centers of excellence often act as adoption hubs, influencing neighboring markets through clinician training and peer-to-peer knowledge transfer.

In Asia-Pacific, rapid adoption of point-of-care ultrasound and expansion of ambulatory surgical capacity are notable trends. Diverse healthcare system maturity across countries creates opportunities for both high-end reusable systems in advanced urban tertiary centres and cost-effective disposable solutions in emerging markets. Local manufacturing capacity and regional trade agreements also influence supply chain design and the feasibility of onshore assembly or packaging to reduce lead times and tariff exposure.

Understanding these regional distinctions enables suppliers and buyers to prioritize investments in distribution networks, clinician education, and regulatory alignment that correspond to each region's operational realities and growth trajectories.

Competitive dynamics driven by clinical validation, platform compatibility, and integrated service models that shape vendor positioning and customer preference

The competitive environment for ultrasound needle guides centers on differentiation through clinical validation, system compatibility, and service offerings rather than commodity pricing alone. Leading companies increasingly pair hardware with clinician training programs, simulation platforms, and installation support to lower the barrier to adoption and to demonstrate procedural value. Strategic partnerships with imaging system manufacturers and clinical institutions strengthen integration and streamline workflow adoption.

Innovation pathways center on materials that enhance ultrasound transmission and sterile barriers, quick-mount adapters that broaden compatibility across probe geometries, and design refinements that improve needle visualization and stability. Several vendors are investing in modularity to enable a single guide platform to accommodate multiple procedures, from peripheral vascular access to biopsy. Post-market surveillance and real-world evidence collection are becoming differentiators, as buyers demand demonstrable reductions in complication rates and improvements in procedural efficiency.

Service models are diversifying. Some companies emphasize bundled offerings that include clinician education and periodic competency assessments, while others focus on scalable consumable supply chains with responsive logistics. For procurement teams, vendor selection often balances product performance, compatibility assurances, and the predictability of supply. In this environment, companies that can demonstrate robust clinical partnerships, flexible commercial terms, and seamless interoperability with a broad range of ultrasound platforms will be positioned to capture preference among clinicians and procurement stakeholders.

Practical actions for manufacturers and providers to enhance adoption, mitigate supply risks, and demonstrate clinical and operational value through targeted investments

Industry leaders can accelerate adoption and create defensible market positions by aligning product development, clinician engagement, and supply chain resilience. Prioritize cross-platform compatibility to reduce friction for clinical teams and to expand addressable use cases across imaging modalities. Invest in materials and design features that improve needle visualization and stability without adding procedural complexity, thereby enhancing clinician trust and reducing training burdens.

Strengthen clinical partnerships and build evidence through targeted observational studies and post-market data collection that focus on safety outcomes and workflow improvements. These data form the basis of compelling clinical value propositions for hospital committees and ambulatory centre administrators. Simultaneously, consider modular commercial offerings that bundle devices with training modules, competency verification, and online resources to shorten the adoption curve and embed vendor support within clinical pathways.

Supply chain diversification is critical; explore regional manufacturing, alternative sourcing strategies, and inventory buffers to mitigate tariff volatility and logistic disruptions. Work closely with procurement teams to offer predictable replenishment models and contractual protections that address short-term cost fluctuations. Finally, frame sustainability initiatives in tangible operational terms-such as validated cleaning protocols for reusable guides and lifecycle assessments-to balance environmental goals with clinical safety and cost considerations.

A rigorous mixed-methods approach combining clinician interviews, hands-on product evaluation, and regulatory and supply chain analysis to ensure actionable and validated insights

This research synthesizes primary insights from clinician interviews, supply chain stakeholder consultations, and product validation reviews together with a structured analysis of regulatory frameworks and public clinical literature. Clinician input was obtained from a cross-section of users in hospitals and clinics, diagnostic imaging centres, ambulatory surgical centres, and physician offices to capture procedural preferences and workflow constraints. Supply chain perspectives were integrated through conversations with operations leads at manufacturing and distribution partners to illuminate sourcing strategies and lead time sensitivities.

Product-level evaluation involved hands-on review of representative disposable and reusable guides, assessment of compatibility with two dimensional, three dimensional and four dimensional imaging systems, and examination of operation modes that span automatic and manual functionality. Application-specific analysis incorporated clinician feedback for anesthesia, biopsy, and vascular access procedures to identify design priorities and usability trade-offs. Regulatory and procurement research included review of regional device classification and infection prevention guidance to contextualize adoption barriers and evidence requirements.

Where possible, triangulation of primary interviews with publicly available clinical studies and device documentation was used to validate claims related to usability, sterility protocols, and alignment with clinical workflows. The approach emphasizes rigor and practical relevance, aiming to present actionable insights that reflect real-world constraints and opportunities for stakeholders across the value chain.

A concise synthesis highlighting how clinical needs, operational realities, and regional nuances converge to shape long-term adoption and competitive advantage

The cumulative picture for ultrasound needle guides is one of pragmatic innovation and differentiated value creation. Clinical demand is increasingly shaped by the need for accurate, reliable guidance that integrates seamlessly with evolving imaging capabilities and diverse procedural settings. This places a premium on compatibility, predictable supply, and demonstrable clinical benefits rather than on isolated device features.

Operational trends such as the shift to ambulatory care, heightened infection control expectations, and sensitivity to total cost of ownership are driving procurement towards solutions that balance disposability and reuse considerations. Vendors that proactively address these dimensions through evidence generation, clinician training, and resilient sourcing will be better positioned to meet purchaser expectations. Regional nuances-from the Americas' throughput-driven decisions to Europe, Middle East & Africa's heterogeneity and Asia-Pacific's mixed maturity-require tailored commercial and regulatory approaches.

Ultimately, success in this segment hinges on aligning product design with clinician needs, reinforcing value through real-world performance data, and building supply chain and service models that minimize procurement friction. Stakeholders who pursue integrated strategies that connect device performance to procedural outcomes and operational efficiencies will capture long-term preference among clinical users and institutional buyers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasound Needle Guides Market, by Product Type

  • 8.1. Disposable
  • 8.2. Reusable

9. Ultrasound Needle Guides Market, by Operation Mode

  • 9.1. Automatic
  • 9.2. Manual

10. Ultrasound Needle Guides Market, by Imaging Type

  • 10.1. Three Dimensional Four Dimensional
  • 10.2. Two Dimensional

11. Ultrasound Needle Guides Market, by End User

  • 11.1. Ambulatory Surgical Centres
    • 11.1.1. Hospital Owned
    • 11.1.2. Independent Centres
  • 11.2. Diagnostic Imaging Centres And Physicians
    • 11.2.1. Imaging Centres
    • 11.2.2. Physicians Offices
  • 11.3. Hospitals And Clinics
    • 11.3.1. Private Clinics
    • 11.3.2. Public Hospitals

12. Ultrasound Needle Guides Market, by Application

  • 12.1. Anesthesia
    • 12.1.1. General
    • 12.1.2. Regional
  • 12.2. Biopsy
    • 12.2.1. Core Needle
    • 12.2.2. Fine Needle
  • 12.3. Vascular Access
    • 12.3.1. Central Line Placement
    • 12.3.2. Peripheral Access

13. Ultrasound Needle Guides Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ultrasound Needle Guides Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ultrasound Needle Guides Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ultrasound Needle Guides Market

17. China Ultrasound Needle Guides Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Argon Medical Devices Inc.
  • 18.6. Becton Dickinson and Company
  • 18.7. Boston Scientific Corporation
  • 18.8. Canon Medical Systems Corporation
  • 18.9. CIVCO Medical Solutions
  • 18.10. Clarius Mobile Health
  • 18.11. Cook Medical Inc.
  • 18.12. EchoNous Inc.
  • 18.13. Esaote S.p.A.
  • 18.14. Fujifilm Holdings Corporation
  • 18.15. GE Healthcare
  • 18.16. Hitachi Medical Systems
  • 18.17. Interson Corporation
  • 18.18. Medtronic plc
  • 18.19. Mindray Medical International Limited
  • 18.20. Philips Healthcare
  • 18.21. Rocket Medical plc
  • 18.22. Samsung Medison Co. Ltd.
  • 18.23. Shimadzu Corporation
  • 18.24. Siemens Healthineers
  • 18.25. Stryker Corporation
  • 18.26. Telemed Ultrasound

LIST OF FIGURES

  • FIGURE 1. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY THREE DIMENSIONAL FOUR DIMENSIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY THREE DIMENSIONAL FOUR DIMENSIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY THREE DIMENSIONAL FOUR DIMENSIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY TWO DIMENSIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY TWO DIMENSIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY TWO DIMENSIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITAL OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITAL OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY INDEPENDENT CENTRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY INDEPENDENT CENTRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY INDEPENDENT CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING CENTRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING CENTRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PHYSICIANS OFFICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PHYSICIANS OFFICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PHYSICIANS OFFICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REGIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REGIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REGIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY CORE NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY CORE NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY CORE NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY FINE NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY FINE NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY FINE NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY CENTRAL LINE PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY CENTRAL LINE PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY CENTRAL LINE PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PERIPHERAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PERIPHERAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PERIPHERAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 203. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 205. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 206. GCC ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 237. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 239. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 241. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 242. G7 ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 243. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 253. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY IMAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTRES AND PHYSICIANS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA ULTRASOUND NEEDLE GUIDES MARKET SIZE, BY VASCULAR ACCESS, 2018-2032 (USD MILLION)